3Mendoza,Wang XS,Cleeland CS,et al.The rapid assessment of atigue severity incancer patienta use of the Brief Fatigue Inventory[J].Cancer,1999,85(5):1186-1196.
4NCCN National comprehensive cancer nework Cancer related fatigue (EB/OL).http//www.nccn.org/porfessionals/physician_gls/PDF/fatigue.pdf.
5Gerrity TR,Papanicolaou DA,Amsterdam JD,etal.Immunological spects of chronic fatigue syndrone[J].Neuroinm Una Modulation,2004,11(6):351-357.
4Santini R, Hosni M, Douse T,et al. Increasing antigenecity of B16 melanoma cell fraction with microware nyperthemia [ J ]. J Microwave power, 1986,21:41.
5Burris H A 3rd, Moore M J, Andersen J,et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial[ J]. J Clin Oncol, 1997,15 (6) :2403-2413.
6van-der Zee J. Heating the patient:a promising approach? [J]. Ann Oncol,2002,13(8) :1173-1184.
7Jakubowicz Gil J, Paduch R, Gawron A, et al. The effect of heat shock, cisplatin, etoposide and quercetin on Hsp27 expression in human normal and tumour cells[J]. Folia Histochem Cytobiol,2002 ,40( 1 ) :31-35.
8Wiedemann G J ,Robins H I,Katschinski D M ,et al. Systemic hyperthermia and ICE chemotherapy for sarcoma patients:rationale and clinical status [J]. Anticancer Res, 1997, 17 (4B) :2899-2902.
9Hildebrandt B,Wust P, Ahlers O,et al. The cellular and molecular basis of hyperthermia [ J ]. Crit Rev Oneol Hematol, 2002,43( 1 ) :33-56.
10Takahashi L,Emi Y, Hasuda S,et al. Clincal application of hyperthermia combined with anticancer drugs for the treatment of solid tumors [ J ]. Surgery ,2002,131 ( 1 Suppl ) :S78-84.
